دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Best Practices for Cardiac Catheterization Laboratory Morbidity and Mortality Conferences
James C. Blankenship, MD, MHCM,a Jacob A. Doll, MD,b Faisal Latif, MD, c Alexander G. Truesdell, MD,d Michael N. Young, MD, e Uzoma N. Ibebuogu, MD, f Saraschandra Vallabhajosyula, MD, MS C, g Sabeeda M. Kadavath, MD,h Camila M. Maestas, MD,i George Vetrovec, MD,j Frederick Welt, MD k
doi : 10.1016/j.jcin.2022.10.017
Volume 16, Issue 5, 13 March 2023, Pages 503-514
Cardiac catheterization laboratory (CCL) morbidity and mortality conferences (MMCs) are a critical component of CCL quality improvement programs and are important for the education of cardiology trainees and the lifelong learning of CCLÂ physicians and team members.
Deformation of Transcatheter Heart Valve Following Valve-in-Valve Transcatheter Aortic Valve Replacement: Implications for Hemodynamics
Miho Fukui, MD, PHD, a Paul Sorajja, MD, b,c João L. Cavalcante, MD, a,c Kiahltone R. Thao, BA, b Atsushi Okada, MD, PHD, b Hirotomo Sato, MD, PHD, b Cheng Wang, MD,b Hideki Koike, MD, PH D, a Nadira Hamid, MD, b,c Maurice Enriquez-Sarano, MD, b John R. Lesser, MD, b,c Vinayak N. Bapat, MD
doi : 10.1016/j.jcin.2023.01.017
Volume 16, Issue 5, 13 March 2023, Pages 515-526
3 Ways to Mitigate the Risk of Transcatheter Heart Valve Underexpansion and Dysfunction in Valve-in-Valve TAVR∗
Frédéric Beaupré, MD,a Philippe Garot, MD
doi : 10.1016/j.jcin.2023.02.001
Volume 16, Issue 5, 13 March 2023, Pages 527-529
Outcomes of Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR
Adnan K. Chhatriwalla, MD, a, * Keith B. Allen, MD, a, * Jeremiah P. Depta, MD, MPHS, b Evelio Rodriguez, MD,c Vinod H. Thourani, MD,d Brian K. Whisenant, MD,e Firas Zahr, MD,f Vinayak Bapat, MD,g Santiago Garcia, MD
doi : 10.1016/j.jcin.2022.12.019
Volume 16, Issue 5, 13 March 2023, Pages 530-539
Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) is increasingly used to treat degenerated surgical bioprostheses. Bioprosthetic valve fracture (BVF) has been shown to improve hemodynamic status in VIV TAVR in case series. However, the safety and efficacy of BVF are unknown.
Bioprosthetic Valve Fracture: Timing Matters∗
Didier Tchetche, MD, Chiara de Biase, MD
doi : 10.1016/j.jcin.2023.01.015
Volume 16, Issue 5, 13 March 2023, Pages 540-541
Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves
Ahmed AlBadri, MD, Jubin Joseph, MD, P HD, Vivek Patel, MS, Dhairya Patel, BDS, Ofir Koren, MD, Wen Cheng, MD, Hasan Jilaihawi, MD, Raj Makkar, MD
doi : 10.1016/j.jcin.2023.01.381
Volume 16, Issue 5, 13 March 2023, Pages 542-554
Internally Stented Bioprosthetic Heart Valves Should Not Be Used Any More
Stefan Toggweiler, MD, Federico Moccetti, MD, Peter Matt, MD
doi : 10.1016/j.jcin.2023.02.009
Volume 16, Issue 5, 13 March 2023, Pages 555-557
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study
Kendra J. Grubb, MD, MHA, a Hemal Gada, MD, MBA, b,c Suneet Mittal, MD,d Tamim Nazif, MD, e Josep Rodés-Cabau, MD, PH D, f,g Douglas G.W. Fraser, MB, BC HIR, BA, DM, h Lang Lin, MD,i,j Joshua D. Rovin, MD,i,j Ramzi Khalil, MD, k Ibrahim Sultan, MD,b,c Blake Gardner, MD,l David Lorenz, MD, m Stanley J. Chetcuti, MD,n,o Nainesh C. Patel, MD,p James E. Harvey, MD, q Paul Mahoney, MD,r Brian Schwartz, MD, s Zubair Jafar, MD,t John Wang, MD,u Srinivasa Potluri, MD,v Amit N. Vora, MD,b,c Carlos Sanchez, MD,w Amy Corrigan, BS, x Shuzhen Li, PHD, y Steven J. Yakubov, MDw
doi : 10.1016/j.jcin.2023.01.016
Volume 16, Issue 5, 13 March 2023, Pages 558-570
Procedural success and clinical outcomes after transcatheter aortic valve replacement (TAVR) have improved, but residual aortic regurgitation (AR) and new permanent pacemaker implantation (PPI) rates remain variable because of a lack of uniform periprocedural management and implantation.
TAVR Protocolization: The Best Formula to “Optimize� Patient Outcomes∗
Marco Barbanti, MD, Giuliano Costa, MD
doi : 10.1016/j.jcin.2023.01.372
Volume 16, Issue 5, 13 March 2023, Pages 571-573
Intraprocedural Residual Mitral Regurgitation and Survival After Transcatheter Edge-to-Edge Repair: Prospective German Multicenter Registry (MITRA-PRO)
Peter Boekstegers, MD,a,b Jörg Hausleiter, MD, c,d Thomas Schmitz, MD, e Alexander Bufe, MD,b,f Thomas Comberg, MD,g Melchior Seyfarth, MD,b,h Christian Frerker, MD, i,j Harald Beucher,a Dennis Rottländer, MD, b,k Satoshi Higuchi, MD,c,d Taoufik Ouarrak,l Steffen Schneider l on behalf of the MITRA-PRO Investigators
doi : 10.1016/j.jcin.2022.12.015
Volume 16, Issue 5, 13 March 2023, Pages 574-585
Residual mitral regurgitation (MR) is thought to be an important predictor of long-term survival following transcatheter edge-to-edge repair (TEER).
Multiparametric Approach for Result Assessment During Transcatheter Edge-to-Edge Repair: Is it the Key for Clinical Success?
Eustachio Agricola, MD,a,b Francesco Ancona, Mda
doi : 10.1016/j.jcin.2023.01.373
Volume 16, Issue 5, 13 March 2023, Pages 586-588
Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair: 1-Year Results From the EXPAND Study
Saibal Kar, MD, a Ralph Stephan von Bardeleben, MD, b Wolfgang Rottbauer, MD, c Paul Mahoney, MD,d Matthew J. Price, MD,e Carmelo Grasso, MD,f Mathew Williams, MD,g Philipp Lurz, MD, h Mustafa Ahmed, MD,i Jörg Hausleiter, MD,j Bassem Chehab, MD, k Jose L. Zamorano, MD,l Federico M. Asch, MD, m Francesco Maisano, MD
doi : 10.1016/j.jcin.2023.01.010
Volume 16, Issue 5, 13 March 2023, Pages 589-602
The third-generation MitraClip NTR/XTR transcatheter edge-to-edge repair system was introduced to assist in leaflet grasping with the longer clip arms of MitraClip XTR and to improve ease of use with the modified delivery catheter.
Optimal Outcomes in Real-World Patients Treated With TEER: Reaching the Pinnacle∗
Benjamin Hibbert, MD, PH D, a Mohamad Alkhouli, MD
doi : 10.1016/j.jcin.2023.01.374
Volume 16, Issue 5, 13 March 2023, Pages 603-605
Neovascularization in Structural Bioprosthetic Valve Dysfunction
Joshua Yoon, BS C,a, * Julius Jelisejevas, MD, a,b,c, * David Meier, MD, a,b,c Hacina Gill, BSC ,a Althea Lai, BSC ,a Michael A. Seidman, MD, PHD, d Geoffrey W. Payne, MSC , PH D, e Anson Cheung, MD, b,c David A. Wood, MD,b,c Jonathon A. Leipsic, MD,b,c John G. Webb, MD, b,c Janarthanan Sathananthan, MBCHB, MPH, a,b,c,y Stephanie L. Sellers, MS C, P HD
doi : 10.1016/j.jcin.2023.01.007
Volume 16, Issue 5, 13 March 2023, Pages 606-608
Bailout Reclipping for Mitral Leaflet Perforation: A Strategy to Overcome Complications During MitraClip Therapy
Hiroyuki Yamamoto, MD, PHD, a Nobuyuki Takahashi, MD, a Tetsuari Onishi, MD, PH D, a Akiko Masumoto, MD,a Hiroshi Tsunamoto, MD, a Hiroya Kawai, MD, P HD, a,b Tomofumi Takaya, MD, P HD
doi : 10.1016/j.jcin.2022.11.013
Volume 16, Issue 5, 13 March 2023, Pages 609-610
Bidirectional Traction Technique to Resolve Mechanical Valve Leaflet Entrapment After Paravalvular Leak Closure
Yiming Qi, MB, a,b Daxin Zhou, MD, a,b Wenzhi Pan, MD,a,b Junbo Ge, MD
doi : 10.1016/j.jcin.2023.01.358
Volume 16, Issue 5, 13 March 2023, Pages 611-613
Veiled Anatomy of the Tricuspid Valve Perimeter: What the Interventionalist Must Know…But Cannot See!
Shumpei Mori, MD, PHD, a Issam D. Moussa, MD, MBA, b Peter Hanna, MD, P HD, a Kalyanam Shivkumar, MD, PH D
doi : 10.1016/j.jcin.2022.11.009
Volume 16, Issue 5, 13 March 2023, Pages 614-616
Percutaneous Removal of a Left Atrial Papillary Fibroelastoma Using AlphaVac Aspiration Thrombectomy
Anas Safadi, MD, Kais Yehyawi, MD, Joseph Danavi, MD
doi : 10.1016/j.jcin.2022.10.048
Volume 16, Issue 5, 13 March 2023, Pages 617-619
Egg or Chicken First?: Is it Really Useful to Achieve Complete Revascularization?
Pier Pasquale Leone, MD *Antonio Colombo, MD
doi : 10.1016/j.jcin.2023.01.371
Volume 16, Issue 5, 13 March 2023, Page 620
Reply: Egg or Chicken First?: Is it Really Useful to Achieve Complete Revascularization?
Christopher P. Kovach, MD, MSc *Stephen W. Waldo, MD
doi : 10.1016/j.jcin.2023.02.006
Volume 16, Issue 5, 13 March 2023, Pages 620-621
Iatrogenic Atrial Septal Defects After Transseptal Transcatheter Mitral Valve Replacement With a Balloon-Expandable Valve
Lauren S. Ranard, MD Mark Lebehn, MD Vivian Ng, MD Tamim Nazif, MD Rebecca T. Hahn, MD Isaac George, MD Martin B. Leon, MD Juan F. Granada, MD Susheel K. Kodali, MD *Torsten P. Vahl, MD
doi : 10.1016/j.jcin.2022.11.011
Volume 16, Issue 5, 13 March 2023, Pages 621-623
First-in-Human Trial of Mechanical-Electric Thrombectomy in Acute Pulmonary Embolism
Asger Andersen, MD, PhD Piotr Musialek, MD, DPhil Aleksander Araszkiewicz, MD, PhD Jacob Schultz, MD, PhD Jens Erik Nielsen-Kudsk, MD, DMSc Lukasz Tekieli, MD, PhD Wojciech Zajdel, MD, PhD Sylwia SÅ‚awek-Szmyt, MD, PhD Yuval Taff, MSc Ido Weinberg, MD
doi : 10.1016/j.jcin.2022.12.021
Volume 16, Issue 5, 13 March 2023, Pages 623-625
Full Issue PDF
doi : 10.1016/S1936-8798(23)00529-0
Volume 16, Issue 5, 13 March 2023, Pages I-CXXVII
